Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


Company Profile for Galapagos NV (GLPG)

Galapagos NV operates as a clinical stage biotech company. The Company develops and commercializes novel medicines and progressing pipelines in biotech with phase 2 programs, phase 1 programs, pre-clinical, and discovery programs.

Contact Information

Galapagos NV

Generaal De Wittelaan L11 A3
Industriepark Mechelen Noord
Mechelen, 2800
Phone: 32-15-34-2900
Fax: 32-15-34-2901

Key Executives for Galapagos NV (GLPG)

Onno Van De StolpeCEO/FounderBart FiliusChief Financial Officer
Piet WigerinckChief Scientific OfficerAndre HoekemaSenior VP:Corporate Dev
Elizabeth GoodwinHead:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil